Results 21 to 30 of about 51,167 (210)

Rib Giant Cell Tumour [PDF]

open access: yesThe Open Cardiovascular and Thoracic Surgery Journal, 2009
A 55 year old woman was admitted because of a slowly growing chest mass. A diagnosis of giant cells tumor (GCT) was made. In sharp contrast to other large bone metaphysis it accounts for < 1 % of all primary rib's neoplasias. The resection included one normal adjacent rib above and below the tumour with all intervening intercostals muscles and pleura ...
Juan C. Collado Otero   +2 more
openaire   +1 more source

HPV infection and immunochemical detection of cell-cycle markers in verrucous carcinoma of the penis [PDF]

open access: yes, 2009
Penile verrucous carcinoma is a rare disease and little is known of its aetiology or pathogenesis. In this study we examined cell-cycle proteins expression and correlation with human papillomavirus infection in a series of 15 pure penile verrucous ...
A Ouban   +58 more
core   +1 more source

Giant cell tumour of the femoral neck: Failure of curettage–cavity filling cementation with screw fixation, a case report

open access: yesTrauma Case Reports, 2019
Background: Giant cell tumours are common primary long bone tumours with femoral neck locations infrequent and notorious for pathological fractures. Treatment with simple curettage often results in local recurrence.
S. Abdulrazak   +4 more
doaj   +1 more source

Imaging features of rare mesenychmal liver tumours: beyond haemangiomas. [PDF]

open access: yes, 2017
Tumours arising from mesenchymal tissue components such as vascular, fibrous and adipose tissue can manifest in the liver. Although histopathology is often necessary for definitive diagnosis, many of these lesions exhibit characteristic imaging features.
Ahmed, Kareem   +7 more
core   +3 more sources

Postsurgical Paracicatricial Cutaneous Satellitosis of Giant Cell Tumour of the Tendon Sheath, Localized Type

open access: yesCase Reports in Dermatology, 2011
Tenosynovial giant cell tumour (localized type) is a tumour of tendon sheaths and interphalangeal joints, affecting the digits and arising from the synovium.
V. Caputo, S. Fiorella, E. Orlando
doaj   +1 more source

The small molecule ephrin receptor inhibitor, GLPG1790, Reduces renewal capabilities of cancer stem cells, showing anti-tumour efficacy on preclinical glioblastoma models [PDF]

open access: yes, 2019
Therapies against glioblastoma (GBM) show a high percentage of failure associated with the survival of glioma stem cells (GSCs) that repopulate treated tumours.
Beirinckx, Filip   +15 more
core   +2 more sources

Use of Denosumab in Children With Osteoclast Bone Dysplasias: Report of Three Cases. [PDF]

open access: yes, 2019
Denosumab has been used successfully to treat disease-associated osteoclast overactivity, including giant cell tumor of bone. Given its mechanism of action, denosumab is a potent potential treatment of other osteoclast bone dysplasias including central ...
Bernthal, Nicholas M   +8 more
core   +2 more sources

Liposomal delivery of hydrophobic RAMBAs provides good bioavailability and significant enhancement of retinoic acid signalling in neuroblastoma tumour cells [PDF]

open access: yes, 2020
Retinoid treatment is employed during residual disease treatment in neuroblastoma, where the aim is to induce neural differentiation or death in tumour cells.
Bilip, Maja   +11 more
core   +4 more sources

Current indications for denosumab in benign bone tumours

open access: yesEFORT Open Reviews, 2023
Denosumab is a fully humanised monoclonal antibody to RANK ligand, inhibiting the RANK–RANKL pathway. It promotes the apoptosis of osteoclast-like giant cells, a secondary ossification and connective tissue formation. Given its high efficacy, denosumab
Antal Imre   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy